The University of Houston's nursing program has received a significant gift to address the nursing industry's workforce shortage. Photo via UH.edu

A University of Houston alumnus and his wife have donated a historic gift to strengthen nursing education and research at his alma mater.

Andy and Barbara Gessner's $20 million gift to the UH College of Nursing was announced this week during National Nurses Week. The contribution will go toward scholarships and fellowships for students, as well as support programming and research to address the shortage of nurses in the workforce. The college has been renamed in honor of the gift to the Andy and Barbara Gessner College of Nursing.

The Gessners’ support of the College of Nursing is inspired by the many caring and giving nurses they know, including their late mothers, who were both nurses. Gertrude Smith Gessner and Mildred Roberson Pottenger dedicated their lives to delivering compassionate health care to their patients and serving their communities with distinction.

“We believe in nurses and we need more of them right now,” Andy Gessner, whose mother and mother-in-law were both nurses, says in a news release. “We’re all going to need a nurse at some time in our lives, and there's just not enough in the workforce or being educated for the future. The primary intent of our gift is to make more nurses available when we need them, now and in the future.”

By 2025, according to the Bureau of Labor Statistics, there will be a shortage of almost 200,000 registered nurses and a rise in demand of 12 percent between now and 2029.

“The silver tsunami is coming,” says Barbara Gessner in the release. “We are certainly going to need more nurses as the population gets older, so the medical profession will be put to the test. It's always been an honorable profession, and we believe in that tender, compassionate care that nurses provide.”

The donation will create three endowed professorships, two of the which will be matched one-to-one as part of the University’s “$100 Million Challenge” for chairs and professorships. Additional endowments funded by the gift, according to UH, will go toward research, nursing education, clinical learning, scholarships, graduate student fellowships, adjunct faculty support and and more.

“Our college of Nursing has been a leader in preparing highly skilled nurses for the workforce, and this comprehensive gift from Andy and Barbara Gessner will take it to the next level,” says UH President Renu Khator. “We are forever grateful to the Gessners for their vision, commitment and passion for nursing education so that we can educate more nurses who will make a positive impact on the lives of patients and in the health care industry.”

Kathryn Tart is the founding dean of the Gessner College of Nursing, and she believes the gift will have a significant impact on the university as well as the industry as a whole.

“This gift will have a lasting impact on the nursing profession and our great city, state and beyond for many years to come,” she says. “We will be able to attract more top faculty and students and increase our research endeavors to further the University’s mission of becoming a top 50 public university. We are so grateful to the Gessners for their support and vision to address the severe nursing shortage.”

In 2019, the Gessner Family Nursing Scholarship was established. To date, the scholarship has provided full tuition to 19 students in the Traditional BSN program.

“Our legacy will not be about what we did, it's what this gift will do,” says Andy Gessner. “We hope that in the coming years, the Gessner College of Nursing will be recognized for excellence and for creating more nurses.”

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston cleantech, space startups named to World Economic Forum cohort

top honor

Two Houston-based startups have been selected to join the World Economic Forum's Technology Pioneers community.

The two-year program aims to help mission-driven, early-stage start-ups scale their innovations through multi-stakeholder initiatives, co-creating partnerships and other gatherings for community members. One-hundred startups are selected each year from around the globe, this year hailing from 23 countries and working in AI, energy, space, biotech markets and more.

Cleantech startup Vaulted Deep was one of 11 energy and climate companies to be named to the cohort. Julia Reichelstein and Omar Abou-Sayed founded the company in 2023. Its technology injects excess organic waste underground to remove carbon dioxide from the atmosphere.

Last year, Vaulted Deep inked a 12-year deal with Microsoft to remove up to 4.9 million metric tons of carbon dioxide from the environment.

The startup has earned several accolades in recent years, including a No. 3 spot on Fast Company’s list of the World’s Most Innovative Companies of 2026. It was also recently named to market intelligence and advisory firm Cleantech Group's annual Global Cleantech 100 list for a second year in a row.

"Waste management is one of the world's great invisible infrastructure systems ... The need for new infrastructure is growing as disposal challenges become more complex and regulations evolve. Vaulted is building the first new disposal pathway for organic waste in decades by putting it deep underground, permanently," the company shared in a LinkedIn post. "This year, we're joining the World Economic Forum's 2026 Tech Pioneers alongside innovators working on the many interconnected challenges shaping our future."

Houston-based Venus Aerospace was also selected to join the cohort, along with six other spacetech companies. The company was founded in 2020 by Sassie and Andrew Duggleby.

The startup specializes in next-generation rocket engine propulsion as a cleaner alternative to traditional combustion engines. The company's rotating detonation rocket engine (RDRE) burns fuel more efficiently and completed a successful high-thrust test flight last year. Venus says it’s the only company in the world that makes a flight-proven, high-thrust RDRE with a “clear path to scaled production.”

"Frontier technologies matter most when they expand what people, industries, and nations can do," Sassie Duggleby, co-founder and CEO of Venus, said in a news release. "For Venus, RDRE does not just represent a more efficient engine. It is a foundation for faster movement, more capable space systems, and new forms of connectivity across the planet. Being named a Technology Pioneer validates the potential of this technology to help shape a future where distance is less limiting."

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston Methodist receives record $110M gift, names future tower

historic gift

Houston Methodist has received the largest gift in the health system's history to establish new funds for neurological, neuroscience, and women’s health research and treatment.

The $110 million gift comes from Houston-based The Brockman Medical Research Foundation, which supports education and research in the science, medicine and healthcare fields. In response, Houston Methodist announced that it will name its forthcoming 26-story hospital facility the Brockman Centennial Tower.

The tower’s entrance will be named the Anna Margaret Bellows Centennial Hall to honor Anna Margaret Bellows, a young camper who died during the Camp Mystic flooding last summer.

“This extraordinary gift accelerates discovery and transforms how care is delivered,” Dr. Marc Boom, president and CEO of Houston Methodist, said in a news release. “We are grateful to The Brockman Medical Research Foundation for its incredible generosity and vision that will help change the lives of generations of patients. Naming Centennial Tower in recognition of this gift reflects the scale of this commitment and its impact on the future of neuroscience, neurological care and women’s health.”

The gift will be divided into two parts:

  • $100 million will go toward creating an innovation fund within the Houston Methodist Academic Institute and the Houston Methodist Neurological Institute
  • $10 million will be devoted to Houston Methodist's Department of Obstetrics and Gynecology

“This tremendous gift will accelerate translational research that broadens our understanding of neurological and other diseases,” Dr. Jenny Chang, president and CEO of the Houston Methodist Academic Institute, added in the release. “It will allow us to leverage state-of-the-art platforms to detect, diagnose and deliver therapeutics, keeping patient care at the center of our mission.”

The Brockman Centennial Tower is expected to open next year in the Texas Medical Center. Spanning more than 1 million square feet, it will house 400 patient beds, an expanded emergency department, new operating rooms and a rooftop garden. It will be connected to Houston Methodist's flagship Paula and Joseph C. “Rusty” Walter III Tower, which opened in 2018. The Centennial Tower was estimated to cost $1.4 billion when announced in 2022.

In addition to the news of the Brockman gift, Houston Methodist also announced this month that it has launched the Houston Methodist Center for Cell and Gene Therapy and tapped an internationally recognized scientist as its leader.

The new center is focused on discovering and developing innovative and cost-effective therapies for a variety of congenital and acquired diseases, including cancer, HIV and cardiovascular disease.

Dr. Malcolm Brenner has been named as the center's inaugural leader and will assume the role starting in October. He will work alongside scientists and support staff from Baylor College of Medicine and Texas Children's Hospital.

Brenner is a professor of pediatrics, medicine, molecular and human genetics and translational biology at Baylor College of Medicine. He is known for making early advances in using bone marrow transplantation as a form of cell therapy and in engineered immune-cell treatments for cancer and infections, according to a release from Houston Methodist.

“Malcolm Brenner is a pioneer in the field of cell and gene therapy and is uniquely qualified to lead Houston Methodist’s research efforts in this field,” Chang added. “His vision and leadership will play a pivotal role in advancing our work in this space.”